.FDA turns down psychedelic MDMA-assisted treatment for PTSD NBC NewsF.D.A. Declines to Accept MDMA Therapy, Finding Even More Study The New York TimesFDA Turns Down Ecstasy-Based Drug The Commercial JournalFDA declines to approve novel MDMA therapy to handle post-traumatic stress disorder, along with ask for more trial data CNNFDA declines to begin with psychedelic to deal with PTSD, asking for even more research study The Washington Article.